Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
27°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neogenomics Inc
(NQ:
NEO
)
16.39
+1.00 (+6.50%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neogenomics Inc
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
7 Analysts Have This To Say About NeoGenomics
December 28, 2023
Via
Benzinga
NeoGenomics to Appeal Ruling
December 28, 2023
Via
ACCESSWIRE
NeoGenomics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Utility of RaDaR for Therapy Response
December 05, 2023
Via
ACCESSWIRE
NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference
November 14, 2023
Via
ACCESSWIRE
What 6 Analyst Ratings Have To Say About NeoGenomics
November 07, 2023
Via
Benzinga
NeoGenomics Reports Third Quarter 2023 Results
November 06, 2023
Via
ACCESSWIRE
Earnings Scheduled For November 6, 2023
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
Where NeoGenomics Stands With Analysts
October 16, 2023
Via
Benzinga
4 Analysts Have This to Say About NeoGenomics
August 21, 2023
Via
Benzinga
NeoGenomics Raises Annual Guidance After Solid Q2 Earnings Beat
August 08, 2023
NeoGenomics, Inc. (NASDAQ: NEO) reported Q2 revenues of $146.92 million, +18% Y/Y, beating the
Via
Benzinga
Bull Of The Day: NeoGenomics
October 24, 2023
NeoGenomics is a small-cap provider of cancer genetics diagnostics. They boast one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer.
Via
Talk Markets
NeoGenomics Announces the Commercial Availability of Two New Tests, Expanding Its Next-Generation Sequencing and Lung Cancer Portfolios
October 24, 2023
Via
ACCESSWIRE
NeoGenomics to Report Third Quarter 2023 Financial Results on November 6, 2023
October 17, 2023
Via
ACCESSWIRE
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
October 17, 2023
EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END
Via
FinancialNewsMedia
NeoGenomics Reports Second Quarter 2023 Results
August 08, 2023
Via
ACCESSWIRE
NeoGenomics's Return On Capital Employed Insights
May 15, 2023
Via
Benzinga
NeoGenomics: Q1 Earnings Insights
May 12, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 08, 2023
Via
Benzinga
Earnings Scheduled For August 11, 2023
August 11, 2023
Companies Reporting Before The Bell • Consolidated Water Co (NASDAQ:CWCO) is estimated to report quarterly earnings at $0.22 per share on revenue of $30.27 million.
Via
Benzinga
NeoGenomics Announces Medicare Coverage for RaDaR Assay for Minimal Residual Disease and Recurrence in Breast Cancer
July 27, 2023
Via
ACCESSWIRE
NeoGenomics to Report Second Quarter 2023 Financial Results on August 8, 2023
July 18, 2023
Via
ACCESSWIRE
NeoGenomics Expands Board of Directors with Appointments of Three Independent Directors
June 29, 2023
Via
ACCESSWIRE
Guardant Health Stock Reaches 80-Plus Relative Strength Rating Benchmark
June 23, 2023
On Friday, Guardant Health stock hit a key performance benchmark, with its Relative Strength Rating rising to 82, up from 78 the day before.
Via
Investor's Business Daily
NeoGenomics' RaDaR Assay for Minimal Residual Disease Receives First Commercial Coverage
June 15, 2023
Via
ACCESSWIRE
NeoGenomics and German Breast Group Announce New Data Demonstrating Clinical Potential of the RaDaR MRD Assay in HR+/HER2- Breast Cancer
June 05, 2023
Via
ACCESSWIRE
NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference
June 01, 2023
Via
ACCESSWIRE
NeoGenomics to Showcase the Transformational Impact of RaDaR(R) Assay for Molecular Residual Disease and Recurrence Monitoring at ASCO
May 30, 2023
Via
ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
May 16, 2023
Via
Benzinga
Earnings Scheduled For May 12, 2023
May 12, 2023
Companies Reporting Before The Bell • Honda Motor Co (NYSE:HMC) is expected to report earnings for its fourth quarter.
Via
Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 09, 2023
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.